PINK

PINK provides exposure to the US healthcare segment while employing a socially responsible approach by partnering with the Susan G. Komen Breast Cancer Foundation. The actively managed fund primarily consists of 80 to 100 companies of all sizes classified under GICS' healthcare sector including firms in the biotech, medtech, gene therapy, and other fast-growing healthcare sub-industries. Although the fund partnered with a well-known breast cancer foundation, it may still invest in companies that are not involved in the development of breast cancer treatments. Constituents are selected based on a fundamental, bottom-up analysis that generally focuses on growth, but may also shift to a value approach depending on certain market conditions. Investors should note that 100% of the fund's net profit, in the form of its annual management fee will be donated to its chosen foundation—which does not have any influence on the fund's holdings and operations.